Generating Potential Protein-Protein Interaction Inhibitor Molecules Based on Physicochemical Properties.

QEPPI molecular generation protein-protein interaction inhibitor rule of five rule of four virtual chemical library

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
26 Jul 2023
Historique:
received: 21 06 2023
revised: 06 07 2023
accepted: 24 07 2023
medline: 14 8 2023
pubmed: 12 8 2023
entrez: 12 8 2023
Statut: epublish

Résumé

Protein-protein interactions (PPIs) are associated with various diseases; hence, they are important targets in drug discovery. However, the physicochemical empirical properties of PPI-targeted drugs are distinct from those of conventional small molecule oral pharmaceuticals, which adhere to the "rule of five (RO5)". Therefore, developing PPI-targeted drugs using conventional methods, such as molecular generation models, is challenging. In this study, we propose a molecular generation model based on deep reinforcement learning that is specialized for the production of PPI inhibitors. By introducing a scoring function that can represent the properties of PPI inhibitors, we successfully generated potential PPI inhibitor compounds. These newly constructed virtual compounds possess the desired properties for PPI inhibitors, and they show similarity to commercially available PPI libraries. The virtual compounds are freely available as a virtual library.

Identifiants

pubmed: 37570623
pii: molecules28155652
doi: 10.3390/molecules28155652
pmc: PMC10420264
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Science and Technology Agency
ID : FOREST, ACT-X
Organisme : Japan Society for the Promotion of Science
ID : KAKENHI

Références

J Med Chem. 2010 Apr 8;53(7):2719-40
pubmed: 20131845
Drug Discov Today Technol. 2004 Dec;1(4):337-41
pubmed: 24981612
J Med Chem. 2002 Jun 6;45(12):2615-23
pubmed: 12036371
Nat Rev Drug Discov. 2004 Apr;3(4):301-17
pubmed: 15060526
J Med Chem. 2002 Apr 11;45(8):1543-58
pubmed: 11931608
J Chem Inf Model. 2020 Dec 28;60(12):5918-5922
pubmed: 33118816
Sci Rep. 2021 Apr 1;11(1):7420
pubmed: 33795749
Trends Pharmacol Sci. 2013 Jul;34(7):393-400
pubmed: 23725674
Nat Rev Drug Discov. 2012 Mar 01;11(3):191-200
pubmed: 22378269
Curr Opin Chem Biol. 2011 Aug;15(4):475-81
pubmed: 21684802
Bioinformatics. 2021 Apr 9;37(1):89-96
pubmed: 33416858
PLoS One. 2020 Jan 17;15(1):e0226021
pubmed: 31951614
Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954
pubmed: 27899562
J Cheminform. 2020 Nov 17;12(1):70
pubmed: 33292482
J Cheminform. 2009 Jun 10;1(1):8
pubmed: 20298526
Sci Rep. 2020 Dec 16;10(1):22104
pubmed: 33328504
ACS Chem Biol. 2020 Jun 19;15(6):1566-1574
pubmed: 32320205
Biomolecules. 2020 Sep 21;10(9):
pubmed: 32967116
Front Med (Lausanne). 2021 Oct 26;8:760762
pubmed: 34765624
Mol Divers. 2019 Feb;23(1):11-18
pubmed: 29971617
Methods. 2017 Dec 1;131:22-32
pubmed: 28802714
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
ChemMedChem. 2014 Apr;9(4):699-705
pubmed: 24504667
Drug Discov Today. 2023 Feb;28(2):103439
pubmed: 36372330
Brief Bioinform. 2022 Jul 18;23(4):
pubmed: 35830870
Database (Oxford). 2016 Mar 15;2016:
pubmed: 26980515
Nat Rev Drug Discov. 2004 Dec;3(12):1047-56
pubmed: 15573103
Adv Appl Bioinform Chem. 2020 Nov 12;13:11-25
pubmed: 33209039
Int J Mol Sci. 2021 Oct 10;22(20):
pubmed: 34681589
Annu Rev Pharmacol Toxicol. 2014;54:435-56
pubmed: 24160698
Nat Chem. 2012 Jan 24;4(2):90-8
pubmed: 22270643

Auteurs

Masahito Ohue (M)

Department of Computer Science, School of Computing, Tokyo Institute of Technology, Kanagawa 226-8501, Japan.

Yuki Kojima (Y)

Department of Computer Science, School of Computing, Tokyo Institute of Technology, Kanagawa 226-8501, Japan.

Takatsugu Kosugi (T)

Department of Computer Science, School of Computing, Tokyo Institute of Technology, Kanagawa 226-8501, Japan.

Articles similaires

Humans Chondrocytes Osteoarthritis Matrix Metalloproteinase 13 Drug Discovery
Neural Networks, Computer Drug Discovery Humans Drug Repositioning
Drug Design Models, Chemical Endopeptidase Clp Drug Discovery Humans
Proteins Drug Discovery Computational Biology

Classifications MeSH